{
    "clinical_study": {
        "@rank": "121052", 
        "arm_group": [
            {
                "arm_group_label": "PL", 
                "arm_group_type": "Experimental", 
                "description": "Placebo once a day orally for 7 days, then lansoprazole 1mg/kg once a day orally for 7 days"
            }, 
            {
                "arm_group_label": "LP", 
                "arm_group_type": "Experimental", 
                "description": "Lansoprazole 1mg/kg orally once a day for 7 days, then placebo orally  once a day for 7 days"
            }
        ], 
        "brief_summary": {
            "textblock": "This study is crossover study to evaluate safety and efficacy of lansoprazole in preterm\n      infants with gastroesophageal reflux."
        }, 
        "brief_title": "Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Premature Infants", 
            "Gastroesophageal Reflux"
        ], 
        "condition_browse": {
            "mesh_term": "Gastroesophageal Reflux"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  preterm infant\n\n          -  symptoms suspecting gastroesophageal reflux\n\n        Exclusion Criteria:\n\n          -  unstable general conditions due infection or acute illness\n\n          -  congenital anomaly in upper gastrointestinal tract including esophagus\n\n          -  drug history of H2, proton pump inhibitor, blocker during last 1 week\n\n          -  medication of warfarin, carbamazepine, phenytoin, rifampin\n\n          -  inappropriate clinical conditions judged by researchers"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "6 Months", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "12", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946971", 
            "org_study_id": "Konect-LASP"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "PL", 
                    "LP"
                ], 
                "intervention_name": "Lansoprazole", 
                "intervention_type": "Drug", 
                "other_name": "lanston LFDT"
            }, 
            {
                "arm_group_label": [
                    "PL", 
                    "LP"
                ], 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Lansoprazole"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 17, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-740"
                }, 
                "name": "Seoul National University Hospital"
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Lansoprazole in Preterm Infants With Gastroesophageal Reflux", 
        "overall_official": {
            "affiliation": "Seoul National University Hospital", 
            "last_name": "Han-Suk Kim, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Korea: Food and Drug Administration", 
                "Korea: Institutional Review Board", 
                "Korea: Ministry for Health, Welfare and Family Affairs"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "measured by 24hr pH impedance monitor", 
            "measure": "Acid reflux time (%)", 
            "safety_issue": "No", 
            "time_frame": "day 0, day 7, day 14"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946971"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Han-Suk Kim", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "measured by 24hr pH impedance monitor", 
                "measure": "Acid reflux frequency", 
                "safety_issue": "No", 
                "time_frame": "day 0, day 7, day 14"
            }, 
            {
                "description": "measured by 24hr pH impedance monitor", 
                "measure": "Composite score", 
                "safety_issue": "No", 
                "time_frame": "day 0, day 7, day 14"
            }, 
            {
                "description": "measured by 24hr pH impedance monitor", 
                "measure": "Acid reflux fraction", 
                "safety_issue": "No", 
                "time_frame": "day 0, day 7, day 14"
            }, 
            {
                "description": "measured by 24hr pH impedance monitor", 
                "measure": "acid bolus reflux time/%,", 
                "safety_issue": "No", 
                "time_frame": "day 0, day 7, day 14"
            }, 
            {
                "description": "measured by 24hr pH impedance monitor", 
                "measure": "nonacid bolus reflux time/%", 
                "safety_issue": "No", 
                "time_frame": "day 0, day 7, day 14"
            }, 
            {
                "description": "measured by 24hr pH impedance monitor", 
                "measure": "bolus reflux time/%", 
                "safety_issue": "No", 
                "time_frame": "day 0, day 7, day 14"
            }, 
            {
                "description": "I-GERQ GERD score chart (Infant Gastroesophageal Reflux Questionnaire Gastroesophageal Reflux Disease)", 
                "measure": "I-GERQ GERD score", 
                "safety_issue": "No", 
                "time_frame": "day 0, day 7, day 14"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}